Home LiteratureArticle Details
PMID: 15713946 Published · ppublish English Comment Editorial

COX-2 inhibitors--lessons in drug safety.

The New England journal of medicine ·Vol. 352 ·No. 11 ·2005-03-17 ·Pages 1133-5

Psaty BM, Furberg CD

Abstract

暂无摘要

MeSH Terms
Cardiovascular Diseases/chemically induced Celecoxib Cyclooxygenase 2 Cyclooxygenase 2 Inhibitors Cyclooxygenase Inhibitors/adverse effects,therapeutic use Drug Approval/legislation & jurisprudence Gastrointestinal Hemorrhage/chemically induced,prevention & control Humans Isoxazoles/adverse effects Lactones/adverse effects Membrane Proteins Prostaglandin-Endoperoxide Synthases Publishing/standards Pyrazoles/adverse effects Randomized Controlled Trials as Topic/standards Research Design Sulfonamides/adverse effects Sulfones/adverse effects United States United States Food and Drug Administration/organization & administration
Chemicals
Cyclooxygenase 2 Inhibitors Cyclooxygenase Inhibitors Isoxazoles Lactones Membrane Proteins Pyrazoles Sulfonamides Sulfones rofecoxib valdecoxib parecoxib Cyclooxygenase 2 PTGS2 protein, human Prostaglandin-Endoperoxide Synthases Celecoxib
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Psaty Bruce M
Furberg Curt D
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
Published
2005-03-17
Epub
2005-00-15
Pages
1133-5
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
CommentOn
CommentOn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com